This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Morrissey, R. P. Articles by Kaul, S. Search for Related Content PubMed PubMed Citation Articles by Morrissey, R. P. Articles by Kaul, S. Related Collections Related Article

Statins in Acute Coronary Syndromes

Do the Guideline Recommendations Match the Evidence?

Ryan P. Morrissey, MD^_*, George A. Diamond, MD^_*, and Sanjay Kaul, MD^_*,,,_*

^_* Cedars-Sinai Medical Center, University of California, Los Angeles, Los Angeles, California
Division of Cardiology, University of California, Los Angeles, Los Angeles, California
David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California
Cedars-Sinai Heart Institute, Los Angeles, California

View larger version (29K): [in this window] [in a new window] [Download PPT slide]   Figure 1 CHD Risk Reduction According to Baseline LDL-C and LDL Lowering Putative relationship of treatment benefit (% coronary heart disease [CHD] risk reduction) according to baseline pre-treatment LDL (from <70 to >100 mg/dl) and % low-density lipoprotein (LDL) lowering (from <10% to >30%). LDL-C = low-density lipoprotein cholesterol.